Back to Authors

Barry, Michael A

0000-0002-8568-5664

Mayo Clinic

Mayo Clinic

Citations 63

Synthesis and Conformational Evaluation of a Novel Gene Delivery Vector for Human Mesenchymal Stem Cells
Saraf, Anita , Hacker, Michael C. , Sitharaman, Balaji , Grande‐Allen, K. Jane , Barry, Michael A. , Mikos, Antonios G. , Barry, Michael A

Biomacromolecules | February 5, 2008 | Volume: 9 | Issue: 3 | Pages: 818-827

10.1021/bm701146f Get It

Polyethylene Glycol Modification of Adenovirus Reduces Platelet Activation, Endothelial Cell Activation, and Thrombocytopenia
Hofherr, Sean, Mok, Hoyin, Gushiken, Francisca C., López, José A. , Barry, Michael A. , Barry, Michael A

Human Gene Therapy | September 3, 2007 | Volume: 18 | Issue: 9 | Pages: 837-848

10.1089/hum.2007.0051 Get It

Cryoelectron Microscopy of Protein IX-Modified Adenoviruses Suggests a New Position for the C Terminus of Protein IX
Marsh, Michael P., Campos, Samuel K. , Baker, Matthew L. , Chen, Christopher Y. , Chiu, Wah , Barry, Michael A. , Barry, Michael A , Campos, Samuel K

Journal of Virology | November 13, 2006 | Volume: 80 | Issue: 23 | Pages: 11881-11886

10.1128/jvi.01471-06 Get It

ABSTRACT Recombinant human adenovirus is a useful gene delivery vector for clinical gene therapy. Minor capsid protein IX of adenovirus has been of recent interest since multiple studies have shown that modifications can be made to its C terminus to alter viral tropism or add molecular tags and/or reporter proteins. We examined the structure of an engineered adenovirus displaying the enhanced green fluorescent protein (EGFP) fused to the C terminus of protein IX. Cryoelectron microscopy and reconstruction localized the C-terminal EGFP fusion between the H2 hexon and the H4 hexon, positioned between adjacent facets, directly above the density previously assigned as protein IIIa. The original assignment of IIIa was based largely on indirect evidence, and the data presented herein support the reassignment of the IIIa density as protein IX.